| Literature DB >> 28347337 |
Thomas M Gill1, Daniel P Beavers2, Jack M Guralnik3, Marco Pahor4, Roger A Fielding5, Michelle Hauser6, Todd M Manini4, Anthony P Marsh7, Mary M McDermott8, Anne B Newman9, Heather G Allore10, Michael E Miller2.
Abstract
BACKGROUND: Among older persons, disability is often precipitated by intervening illnesses and injuries leading to hospitalization. In the Lifestyle Interventions and Independence for Elders (LIFE) Study, a structured moderate-intensity physical activity program, compared with a health education program, was shown to significantly reduce the amount of time spent with major mobility disability (MMD) over the course of 3.5 years. We aimed to determine whether the benefit of the physical activity program in promoting independent mobility was diminished in the setting of intervening hospitalizations.Entities:
Keywords: Hospitalizations; Mobility disability; Physical activity; Randomized controlled trial
Mesh:
Year: 2017 PMID: 28347337 PMCID: PMC5368996 DOI: 10.1186/s12916-017-0824-6
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Fig. 1Flow of participants through the study. *Participants who did not receive the allocated intervention (i.e., attended no intervention sessions). †For participants who did not have any major mobility disability (MMD) assessments, we assigned 1 hour of follow-up time, because we knew that they were able to complete the 400-m walk at baseline. SPPB Short Physical Performance Battery
Baseline characteristics of participants by study group
| Physical activity | Health education | |
|---|---|---|
| Age in years, mean (SD) | 78.7 (5.2) | 79.1 (5.2) |
| Female sex, n (%) | 547 (66.9) | 551 (67.4) |
| Race/ethnicity, n (%) | ||
| White, non-Hispanic | 604 (73.8) | 635 (77.7) |
| Black, non-Hispanic | 163 (19.9) | 125 (15.3) |
| Hispanic | 31 (3.8) | 30 (3.7) |
| Other | 20 (2.4) | 27 (3.3) |
| Education beyond high school, n (%) | 544 (66.6) | 550 (67.7) |
| Number of chronic conditions, mean (SD) | 1.6 (1.1) | 1.7 (1.0) |
| Hypertension, n (%) | 573 (70.5) | 578 (71.5) |
| Cardiovascular diseasea, n (%) | 236 (28.9) | 254 (31.1) |
| Diabetes, n (%) | 199 (24.4) | 216 (26.6) |
| Cancer, n (%) | 178 (21.9) | 192 (23.6) |
| Chronic pulmonary disease, n (%) | 130 (16.0) | 123 (15.2) |
| 3MSE score, mean (SD) | 91.5 (5.5) | 91.6 (5.3) |
| SPPB score | ||
| Mean (SD) | 7.4 (1.6) | 7.3 (1.6) |
| <8, n (%) | 353 (43.2) | 378 (46.3) |
Abbreviations: 3MSE Modified Mini-Mental State Examination (0–100 scale), SD standard deviation, SPPB Short Physical Performance Battery
aIncludes the presence of any of the following: self-report of a physician-diagnosed heart attack or myocardial infarction, stroke or brain hemorrhage accompanied by hospitalization, or heart failure; evidence of myocardial infarction based on a baseline electrocardiogram; or ankle brachial index ≤0.9 in either leg
Hospital exposures by study group according to mobility outcome
| Physical activity | Health education | |
|---|---|---|
| Initial onset of MMDa | ||
| Participants at risk, n | 818 | 817 |
| Participants hospitalized, n (%) | 349 (42.9) | 301 (36.8) |
| Time in years to first hospitalization, median (IQR) | 1.0 (0.5–1.8) | 1.1 (0.5–1.9) |
| Hospitalizations, n | 611 | 501 |
| Per participant, mean (SD) | 0.8 (1.2) | 0.6 (1.1) |
| Per participant hospitalized, mean (SD) | 1.8 (1.2) | 1.7 (1.2) |
| Days hospitalized, n | 2679 | 2195 |
| Per participant, mean (SD) | 3.3 (7.4) | 2.7 (6.3) |
| Per participant hospitalized, mean (SD) | 7.7 (9.8) | 7.3 (8.5) |
| Recovery from MMDb | ||
| Participants at risk, n | 246 | 290 |
| Participants hospitalized, n (%) | 72 (29.3) | 87 (30.0) |
| Time in years to first hospitalization, median (IQR) | 0.3 (0.1–0.6) | 0.3 (0.2–0.8) |
Abbreviations: IQR interquartile range, MMD major mobility disability, SD standard deviation
aFrom time of randomization to initial onset of MMD, which occurred in 246 (30.0%) and 290 (35.5%) of participants in the physical activity and health education groups
bFrom time of initial MMD onset to first recovery, which occurred in 89 (36.2%) and 98 (33.8%) of participants in the physical activity and health education groups
Reasons for hospitalization according to mobility outcome and study group
| Initial onset of MMD | Recovery from MMD | |||
|---|---|---|---|---|
| Physical activity | Health education | Physical activity | Health education | |
| Reason for hospitalizationa |
|
|
|
|
| Blood and lymphatic system disorders | 16 (2.6) | 11 (2.2) | 0 (0.0) | 1 (0.3) |
| Cardiac disorders | 86 (14.1) | 72 (14.4) | 28 (11.4) | 19 (6.6) |
| Ear and labyrinth disorders | 3 (0.5) | 5 (1.0) | 2 (0.8) | 1 (0.3) |
| Endocrine disorders | 5 (0.8) | 1 (0.2) | 0 (0.0) | 0 (0.0) |
| Gastrointestinal disorders | 66 (10.8) | 41 (8.2) | 15 (6.1) | 10 (3.4) |
| General disorders and administration site conditions | 21 (3.4) | 13 (2.6) | 2 (0.8) | 6 (2.1) |
| Hepatobiliary disorders | 8 (1.3) | 5 (1.0) | 0 (0.0) | 1 (0.3) |
| Immune system disorders | 6 (1.0) | 2 (0.4) | 1 (0.4) | 1 (0.3) |
| Infections and infestations | 58 (9.5) | 42 (8.4) | 12 (4.9) | 12 (4.1) |
| Injury, poisoning, and procedural complications | 40 (6.5) | 43 (8.6) | 17 (6.9) | 15 (5.2) |
| Investigations | 4 (0.7) | 1 (0.2) | 0 (0.0) | 1 (0.3) |
| Metabolism and nutrition disorders | 19 (3.1) | 14 (2.8) | 6 (2.4) | 6 (2.1) |
| Musculoskeletal and connective tissue disorders | 37 (6.1) | 50 (10.0) | 13 (5.3) | 13 (4.5) |
| Neoplasms: benign, malignant, and unspecifiedb | 13 (2.1) | 14 (2.8) | 4 (1.6) | 4 (1.4) |
| Nervous system disorders | 65 (10.6) | 48 (9.6) | 15 (6.1) | 17 (5.9) |
| Psychiatric disorders | 6 (1.0) | 2 (0.4) | 1 (0.4) | 1 (0.3) |
| Renal and urinary disorders | 11 (1.8) | 11 (2.2) | 4 (1.6) | 3 (1.0) |
| Reproductive system and breast disorders | 4 (0.7) | 3 (0.6) | 0 (0.0) | 0 (0.0) |
| Respiratory, thoracic, and mediastinal disorders | 47 (7.7) | 35 (7.0) | 13 (5.3) | 5 (1.7) |
| Skin and subcutaneous tissue disorders | 2 (0.3) | 6 (1.2) | 0 (0.0) | 1 (0.3) |
| Surgical and medical procedures | 65 (10.6) | 64 (12.8) | 10 (4.1) | 16 (5.5) |
| Vascular disorders | 29 (4.7) | 18 (3.6) | 6 (2.4) | 8 (2.8) |
Data are presented as n (%).
Abbreviations: MMD major mobility disability
aBased on MedDRA system Organ Class, listed alphabetically, as described in the Methods
bIncludes cysts and polyps
Attendance at the center-based physical activity sessions
| Onset of MMD (N = 818) | Recovery from MMD (N = 246) | |||
|---|---|---|---|---|
| Medical leave | Before hospitalization | After hospitalization | Before hospitalization | After hospitalization |
| Included | 61.4 (59.5–63.2) | 23.9 (20.9–26.9) | 28.5 (23.6–33.4) | 8.3 (3.8–12.9) |
| Excluded | 74.7 (73.2–76.1) | 60.7 (56.7–64.5) | 48.5 (42.4–54.6) | 29.1 (16.7–41.4) |
Data are presented as the mean percentage (95% confidence interval).
Attendance was calculated separately for each 6-month interval, i.e., the time between the follow-up visits, and these values were aggregated across the intervals as described in the Methods. For the onset of MMD, values were calculated as the number of sessions attended divided by the number scheduled during the periods from: (1) no MMD to first hospitalization or next MMD assessment (or censoring) if no hospitalization occurred, and (2) first hospitalization to next MMD assessment (or censoring). For recovery from MMD, similar calculations were performed, except that the beginning of the period was defined by MMD (rather than no MMD). Intervals after MMD recovery were not included in these calculations
Abbreviations: CI confidence interval, MMD major mobility disability
Association between hospital exposures and mobility outcomes according to study group
| Physical activity (N = 818) | Health education (N = 817) | ||||||
|---|---|---|---|---|---|---|---|
| Outcome rate per 100 person-year | Outcome rate per 100 person-year | ||||||
| Exposurea | Hospitalized | Not hospitalized | HR (95% CI) | Hospitalized | Not hospitalized | HR (95% CI) |
|
|
| |||||||
| Any hospitalization | 39 (31–48) | 10 (8–13) | 3.3 (2.5–4.3) | 46 (37–59) | 14 (11–16) | 3.2 (2.5–4.1) | 0.903 |
| Number of hospitalizations | |||||||
| 0 (ref) | 10 (8–13) | 1.0 | 14 (11–16) | 1.0 | 0.742 | ||
| 1 | 36 (28–46) | 3.0 (2.2–4.0) | 39 (30–51) | 2.7 (2.0–3.6) | |||
| 2 or more | 50 (34–73) | 4.3 (2.8–6.8) | 79 (57–109) | 5.1 (3.4–7.6) | |||
| Number of days hospitalizedb | |||||||
| 0 (ref) | 13 (11–15) | 1.0 | 16 (13–19) | 1.0 | 0.804 | ||
| 3 | 15 (13–18) | 1.2 (1.2–1.3) | 19 (16–23) | 1.2 (1.2–1.3) | |||
| 10 | 23 (19–28) | 1.9 (1.6–2.1) | 29 (24–36) | 1.9 (1.6–2.2) | |||
| Any hospitalizationc |
| ||||||
| Model 1 | 43 (27–69) | 64 (46–89) | 0.60 (0.35–1.04) | 33 (21–53) | 51 (37–70) | 0.51 (0.28–0.90) | 0.670 |
| Model 2 | 52 (33–80) | 71 (50–99) | 0.59 (0.39–0.88) | 34 (21–54) | 56 (40–77) | 0.45 (0.27–0.74) | 0.392 |
| Model 3 | 43 (27–68) | 64 (46–89) | 0.60 (0.35–1.03) | 33 (21–53) | 51 (37–69) | 0.51 (0.29–0.92) | 0.688 |
Abbreviations: CI confidence interval, HR hazard ratio, MMD major mobility disability, ref reference group
* Values represent statistical interaction between exposure and study group on mobility outcome
aAssessed during the interval preceding the outcome
b Values for outcome rates are provided for a range of fixed values assuming a log-linear relationship. Three days was the median length of hospital stay, and 10 days allowed for long lengths of stay and more than one hospital admission
c Results are not available for the number of hospitalizations or number of days hospitalized because the number of participants with more than one hospitalization during the at-risk period was small
d All models include clinical site, age, and gender as covariates; Model 2 uses inverse probability weighting based on MMD, whereas Model 3 uses inverse probability weighting based on withdrawal/missed follow-up, as described in the Methods
Fig. 2Associations between any hospitalization and (a) onset of major mobility disability (MMD) and (b) recovery from MMD according to study group and severity of functional limitations. CI confidence interval, SPPB Short Physical Performance Test
Effect of physical activity on mobility outcomes within levels of hospital exposure
| Exposurea | Operational definition | HR (95% CI) |
|
|---|---|---|---|
|
| |||
| Any hospitalization | Not hospitalized | 0.77 (0.62–0.95) | 0.903 |
| Hospitalized | 0.79 (0.58–1.1) | ||
| Number of hospitalizations | 0 | 0.77 (0.62–0.95) | 0.742 |
| 1 | 0.85 (0.59–1.2) | ||
| 2 or more | 0.66 (0.37–1.2) | ||
| Number of days hospitalizedb | 0 | 0.79 (0.66–0.95) | 0.804 |
| 3 | 0.80 (0.67–0.95) | ||
| 10 | 0.81 (0.65–1.0) | ||
|
| |||
| Any hospitalizationc | |||
| Model 1 | Not hospitalized | 1.2 (0.88–1.7) | 0.670 |
| Hospitalized | 1.5 (0.71–3.0) | ||
| Model 2 | Not hospitalized | 1.2 (0.94–1.6) | 0.392 |
| Hospitalized | 1.6 (0.90–2.9) | ||
| Model 3 | Not hospitalized | 1.3 (0.88–2.1) | 0.477 |
| Hospitalized | 2.0 (0.71–5.4) | ||
Abbreviations: CI confidence interval, HR hazard ratio, MMD major mobility disability
* Values represent statistical interaction between exposure and study group on mobility outcome
a Assessed during the interval preceding the outcome
b Results are provided for a range of fixed values. Three days was the median length of hospital stay, and 10 days allowed for long lengths of stay and more than one hospital admission
c Results are not available for the number of hospitalizations or number of days hospitalized because the number of participants with more than one hospitalization during the at-risk period was small
d All models include clinical site, age, and gender as covariates; Model 2 uses inverse probability weighting based on MMD, whereas Model 3 uses inverse probability weighting based on withdrawal/missed follow-up, as described in the Methods
Fig. 3Effect of Physical Activity on (a) onset of major mobility disability (MMD) and (b) recovery from MMD according to hospital exposure and severity of functional limitations. CI confidence interval, SPPB Short Physical Performance Test